About Matthew Martin
Form D filings for Strata Oncology from 2016 to 2024 list Matthew Martin as chief financial officer.
Matthew Martin first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Martin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Martin works with at each company, as listed on that company's latest Form D.
Strata Oncology, Inc. · Form D, Nov 22, 2024
DR
Daniel Rhodes
Executive officer and director
KF
Keith Flaherty
Director
Christopher O'Donnell
Director
JW
Jeffrey Williams
Executive officer and director
DR
David Rubin
Director
JP
James Pavlik
Director
JG
Jan Garfinkle
Director